Insider Transactions Reported by 18 Insiders of Crinetics Pharmaceuticals, Inc.

Symbol
CRNX on Nasdaq
Location
San Diego, CA

Insiders trading volume in the past year

Crinetics Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
PERCEPTIVE ADVISORS LLC 10%+ Owner $200,336,855 18 Apr 2022
Richard Scott Struthers President & CEO, Director $78,242,444 -$773,017 -0.98% 23 Feb 2026
Stephen F. Betz Chief Scientific Officer $8,226,136 -$3,339,230 -29% 23 Feb 2026
Ajay Madan Chief Development Officer $7,783,510 28 Feb 2022
Jeff E. Knight Chief Operating Officer $6,790,226 -$244,964 -3.5% 23 Feb 2026
Tobin Schilke Chief Financial Officer $4,724,405 23 Feb 2026
WENDALL WIERENGA Director $3,869,984 11 Jun 2025
Dana Pizzuti Chief Med and Dev Officer $3,009,001 -$1,996,320 -40% 01 Dec 2025
Isabel Kalofonos Chief Commercial Officer $1,939,905 -$137,500 -6.6% 23 Feb 2026
Marc Wilson Cfo $1,671,244 31 Dec 2024
Alan Seth Krasner Chief Medical Officer $1,626,857 17 Oct 2023
James Hassard Chief Commercial Officer $1,289,737 05 Jul 2024
Matthew K. Fust Director $1,021,911 -$716,000 -41% 26 Sep 2025
Coelho Rogerio Vivaldi Director $709,716 11 Jun 2025
Camille L. Bedrosian Director $543,116 11 Jun 2025
Stephanie Okey Director $543,116 11 Jun 2025
Weston Nichols Director $543,116 11 Jun 2025
Caren Deardorf Director $543,116 11 Jun 2025

Recent Insider Transactions by Companies or Individuals for Crinetics Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.